Stock Detail
STEMCELLS INC
Biotechnology
STEM @ Yahoo Finance | STEM Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $1.85 | $1.91 | $-0.04 | -2.12% | 0.00 | $1.89 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $1.89 | $1.85 | 37,129 | 26.5M | 91,780.5 | -1.09 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 1.93 | 1.89 | 1.87 | 1.83 | 1.81 |
Stock Profile
StemCells, Inc., a biotechnology company, engages in the discovery, development, and commercialization of stem cell-based therapies to treat diseases of the nervous system, liver, and pancreas. It develops therapies that use stem and progenitor cells to treat human diseases and injuries, such as neurodegenerative diseases, including Batten's, Parkinson's, and Alzheimer's diseases, and other metabolic genetic disorders. The company also develops its products for demyelinating disorders, including spinal cord injuries, stroke, hepatitis, chronic liver failure, and diabetes; and multiple sclerosis. StemCells is headquartered in Palo Alto, California.